These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
234 related articles for article (PubMed ID: 24528163)
1. In vitro and in vivo antitumor effects of folate-targeted ursolic acid stealth liposome. Yang G; Yang T; Zhang W; Lu M; Ma X; Xiang G J Agric Food Chem; 2014 Mar; 62(10):2207-15. PubMed ID: 24528163 [TBL] [Abstract][Full Text] [Related]
2. Co-delivery of Bmi1 small interfering RNA with ursolic acid by folate receptor-targeted cationic liposomes enhances anti-tumor activity of ursolic acid Li W; Yan R; Liu Y; He C; Zhang X; Lu Y; Khan MW; Xu C; Yang T; Xiang G Drug Deliv; 2019 Dec; 26(1):794-802. PubMed ID: 31366257 [TBL] [Abstract][Full Text] [Related]
3. In vivo fate of folate-targeted polyethylene-glycol liposomes in tumor-bearing mice. Gabizon A; Horowitz AT; Goren D; Tzemach D; Shmeeda H; Zalipsky S Clin Cancer Res; 2003 Dec; 9(17):6551-9. PubMed ID: 14695160 [TBL] [Abstract][Full Text] [Related]
4. Improved therapeutic activity of folate-targeted liposomal doxorubicin in folate receptor-expressing tumor models. Gabizon A; Tzemach D; Gorin J; Mak L; Amitay Y; Shmeeda H; Zalipsky S Cancer Chemother Pharmacol; 2010 May; 66(1):43-52. PubMed ID: 19779718 [TBL] [Abstract][Full Text] [Related]
5. Antitumor effect of folate-targeted liposomal doxorubicin in KB tumor-bearing mice after intravenous administration. Riviere K; Huang Z; Jerger K; Macaraeg N; Szoka FC J Drug Target; 2011 Jan; 19(1):14-24. PubMed ID: 20353291 [TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of a novel lipophilic folate receptor targeting ligand. Liu Y; Xu S; Teng L; Yung B; Zhu J; Ding H; Lee RJ Anticancer Res; 2011 May; 31(5):1521-5. PubMed ID: 21617205 [TBL] [Abstract][Full Text] [Related]
7. Folic acid-coupled nano-paclitaxel liposome reverses drug resistance in SKOV3/TAX ovarian cancer cells. Tong L; Chen W; Wu J; Li H Anticancer Drugs; 2014 Mar; 25(3):244-54. PubMed ID: 24275314 [TBL] [Abstract][Full Text] [Related]
8. Folate receptor-targeted fluorescent paramagnetic bimodal liposomes for tumor imaging. Ding N; Lu Y; Lee RJ; Yang C; Huang L; Liu J; Xiang G Int J Nanomedicine; 2011; 6():2513-20. PubMed ID: 22072885 [TBL] [Abstract][Full Text] [Related]
9. Preparation, characterization, and antitumor activity of paclitaxel-loaded folic acid modified and TAT peptide conjugated PEGylated polymeric liposomes. Niu R; Zhao P; Wang H; Yu M; Cao S; Zhang F; Chang J J Drug Target; 2011 Jun; 19(5):373-81. PubMed ID: 20677917 [TBL] [Abstract][Full Text] [Related]
10. Preparation and in vitro evaluation of a folate-linked liposomal curcumin formulation. Lu Y; Ding N; Yang C; Huang L; Liu J; Xiang G J Liposome Res; 2012 Jun; 22(2):110-9. PubMed ID: 22372871 [TBL] [Abstract][Full Text] [Related]
11. Targeted poly (L-γ-glutamyl glutamine) nanoparticles of docetaxel against folate over-expressed breast cancer cells. Tavassolian F; Kamalinia G; Rouhani H; Amini M; Ostad SN; Khoshayand MR; Atyabi F; Tehrani MR; Dinarvand R Int J Pharm; 2014 Jun; 467(1-2):123-38. PubMed ID: 24680951 [TBL] [Abstract][Full Text] [Related]
12. Targeting of pegylated liposomal mitomycin-C prodrug to the folate receptor of cancer cells: Intracellular activation and enhanced cytotoxicity. Patil Y; Amitay Y; Ohana P; Shmeeda H; Gabizon A J Control Release; 2016 Mar; 225():87-95. PubMed ID: 26809007 [TBL] [Abstract][Full Text] [Related]
13. A Carrier-Free Folate Receptor-Targeted Ursolic Acid/Methotrexate Nanodelivery System for Synergetic Anticancer Therapy. Lan JS; Qin YH; Liu L; Zeng RF; Yang Y; Wang K; Ding Y; Zhang T; Ho RJY Int J Nanomedicine; 2021; 16():1775-1787. PubMed ID: 33692622 [TBL] [Abstract][Full Text] [Related]
14. Baicalin loaded in folate-PEG modified liposomes for enhanced stability and tumor targeting. Chen Y; Minh LV; Liu J; Angelov B; Drechsler M; Garamus VM; Willumeit-Römer R; Zou A Colloids Surf B Biointerfaces; 2016 Apr; 140():74-82. PubMed ID: 26741267 [TBL] [Abstract][Full Text] [Related]
15. Preparation and body distribution of freeze-dried powder of ursolic acid phospholipid nanoparticles. Zhou XJ; Hu XM; Yi YM; Wan J Drug Dev Ind Pharm; 2009 Mar; 35(3):305-10. PubMed ID: 18798089 [TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of folate receptor-targeted liposomal doxorubicin in a KB oral carcinoma murine xenograft model. Pan XQ; Wang H; Lee RJ Pharm Res; 2003 Mar; 20(3):417-22. PubMed ID: 12669962 [TBL] [Abstract][Full Text] [Related]
17. Dendrimeric anticancer prodrugs for targeted delivery of ursolic acid to folate receptor-expressing cancer cells: synthesis and biological evaluation. Gao Y; Li Z; Xie X; Wang C; You J; Mo F; Jin B; Chen J; Shao J; Chen H; Jia L Eur J Pharm Sci; 2015 Apr; 70():55-63. PubMed ID: 25638419 [TBL] [Abstract][Full Text] [Related]
18. Self-assembly and cytotoxicity study of PEG-modified ursolic acid liposomes. Zhao T; Liu Y; Gao Z; Gao D; Li N; Bian Y; Dai K; Liu Z Mater Sci Eng C Mater Biol Appl; 2015 Aug; 53():196-203. PubMed ID: 26042707 [TBL] [Abstract][Full Text] [Related]
19. Liposome encapsulation of zoledronic acid results in major changes in tissue distribution and increase in toxicity. Shmeeda H; Amitay Y; Tzemach D; Gorin J; Gabizon A J Control Release; 2013 May; 167(3):265-75. PubMed ID: 23419948 [TBL] [Abstract][Full Text] [Related]
20. Folate-liposome-mediated antisense oligodeoxynucleotide targeting to cancer cells: evaluation in vitro and in vivo. Leamon CP; Cooper SR; Hardee GE Bioconjug Chem; 2003; 14(4):738-47. PubMed ID: 12862426 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]